Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Syphilis mimicking malignancy: a lesson in diagnostic uncertainty
AuthorsMohammad Naem; Ahmed Hafez; Halil Tekiner; Eileen S. Yale; Steven H. Yale
Affiliations1. University of Central Florida College of Medicine, Orlando, USA; 2. Department of the History of Medicine and Ethics, Erciyes University School of Medicine, Melikgazi, Turkey; 3. Lake Erie College of Osteopathic Medicine, Jacksonville, USA
Trends in meglumine antimoniate prescriptions in Spain (2016–2024): a proxy for cutaneous leishmaniasis burden
AuthorsAna Pulido-Perez; Irene Fuertes; Merce Grau-Perez
Affiliations1. Department of Dermatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; 2. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain; 3. Grupo de Enfermedades Infecciosas en Dermatología de la AEDV (GEID), Madrid, Spain; 4. Department of Dermatology, Hospital Clinic, Barcelona, Spain; 5. Department of Dermatology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain; 6. Research Unit, Academia Española de Dermatología y Venereología (AEDV), Madrid, Spain
Prehospital blood cultures in suspected sepsis: no need to wait until hospital arrival!
AuthorsVincent Garrouste; Romain Jouffroy
Affiliations1. Emergency Department, SAMU, Orléans la Source Hospital, Orléans, France; 2. LI²RSO, Orléans University, Orléans University Hospital, Orléans, France; 3. Service d’accueil des urgences, 45 – SMUR Orléans, Orléans University Hospital and Orléans University, Orléans, France; 4. Sport’s Medicine Department, Orléans University, Orléans University Hospital, Orléans, France
Epidemiological trends of invasive Streptococcus pyogenes infections in Catalonia, 2022–2024: a two-year analysis
AuthorsMarta Martorell; Aurora Sabrià; Victoria Rello-Saltor; Antoni Soriano-Arandes; Damaris Berbel; Cristina Esteva; M. Dolors Estivill; Silvia Capilla; Teresa Llovet; Inés Valle; F. Xavier Queralt; Mireia Rajadell; M. Dolores Quesada; Maria Navarro; Frederic Gomez-Bertomeu; Yuliya Poliakova; Alba Bellés; Laura Solaz; Ana Siverio; Guillem Vidal; Mar Olga Perez-Moreno; Claudia Miralles; Elisabet Folch; Natàlia Roca; Mariana Fernandez-Pittol; Jordi Duran; Pep Ballester; Carme Gallés; Belén Viñado; Sonia Broner; Jacobo Mendioroz; Pilar Ciruela
Affiliations1. Public Health Agency of Catalonia, General Sub-Directorate for Surveillance and Response to Public Health Emergencies, Department of Health, Generalitat de Catalunya, Barcelona, Spain; 2. Department of Paediatrics, Hospital Universitari Vall d’Hebron, Barcelona, Spain; 3. Serveis de Salut Integrats del Baix Empordà, Palamós, Spain; 4. Infection and Immunity in Children, Vall d’Hebron Research Institute, Barcelona, Spain; 5. Department of Microbiology, Hospital Universitari Bellvitge, Barcelona, Spain; 6. Research Network for Respiratory Diseases (CIBERES), Instituto Salud Carlos III, Madrid, Spain; 7. Department of Microbiology, Hospital Sant Joan de Déu, Barcelona, Spain; 8. Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; 9. Althaia Xarxa Assistencial Universitària Manresa, Manresa, Spain; 10. Microbiology Laboratory, Clinical Laboratories Department, Parc Taulí Hospital Universitari, Sabadell, Spain; 11. Department of Microbiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; 12. Laboratori de Referència de Catalunya, Hospital de Mataró, Mataró, Spain; 13. Hospital Universitari Doctor Trueta, Girona, Spain; 14. Department of Microbiology, CatLab, Barcelona, Spain; 15. Department of Microbiology, Hospital Germans Trias i Pujol, Badalona, Spain; 16. Department of Microbiology, Hospital Universitari de Vic, Barcelona, Spain; 17. Department of Microbiology, Laboratori Clínic ICS Camp de Tarragona, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain; 18. IISPV (Instituto de Investigación Sanitaria Pere Virgili), Tarragona, Spain; 19. Department of Microbiology, CLILAB Diagnostics, Vilafranca Del Penedès, Barcelona, Spain; 20. Department of Microbiology, Hospital Universitari Arnau de Vilanova, Institut de Recerca Biomèdica de Lleida – Fundació Dr. Pifarré, IRBLleida, Lleida, Spain; 21. Department of Microbiology, Hospital Universitari Sant Joan de Reus, Tarragona, Spain; 22. Department of Microbiology, Hospital del Mar, Barcelona, Spain; 23. Department of Microbiology, Hospital de l’Esperit Sant, Barcelona, Spain; 24. Àrea de Microbiologia, Hospital Universitari de Tortosa Verge de la Cinta, Institut Català de la Salut, Tortosa, Spain; 25. Laboratori Hospital Comarcal de Móra d’Ebre, Tarragona, Spain; 26. Centre d’Anàlisis Girona, Girona, Spain; 27. Laboratori Echevarne, Barcelona, Spain; 28. Department of Microbiology, CDB- Hospital Clínic de Barcelona, Barcelona, Spain; 29. Mdb Laboratori d’Anàlisis Clíniques, Barcelona, Spain; 30. Fundació Salut Empordà, Figueres, Spain; 31. Department of Microbiology, Corporació de Salut del Maresme i la Selva, Calella, Spain; 32. Department of Microbiology, Hospital Universitari Vall d’Hebron, Barcelona, Spain; 33. CIBER Epidemiología y Salud Pública (CIBERESP), Instituto Salud Carlos III, Madrid, Spain
Volume control but structural imbalance: AWaRe-based assessment of antimicrobial stewardship in Shanghai, China (2016–2024)
AuthorsQianqian Yu; Biao Wang; Rui Huang; Qingwei Tang; Li Luo
Affiliations1. School of Public Health, Fudan University, Shanghai, China; 2. Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China
When Ebola meets conflict: surveillance vulnerability in the Bundibugyo outbreak
AuthorsEmad M. Abdallah; Samy Selim
Affiliations1. Department of Biology, College of Science, Qassim University, Buraydah, Saudi Arabia; 2. Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia
Radiographic resolution of presumed cerebellar tuberculoma during extended BPaLM-based therapy for disseminated multidrug-resistant tuberculosis
AuthorsRobert C. Flowers; Philip E. Dormish; Alexandria E. Imperato; Caralee E. Caplan-Shaw
Affiliations1. Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, NYU Grossman School of Medicine, New York, USA; 2. NYC Health + Hospitals/Bellevue, New York, USA
Hyper-activated low-density neutrophil-derived NGAL predicts fatal SFTS: a multi-cohort and single-cell study
AuthorsGuangqi Zhu; Zhuolin Han; Bei Jia; Yi Zhang; Yali Xiong; SuKun Kai; Jie Wang; Lifen Hu; Jihua Xue; Chao Wu; Jie Li; Wei Wu
Affiliations1. Department of Infectious Diseases, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China; 2. Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, China; 3. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, China-Singapore Belt and Road Joint Laboratory on Infection Research and Drug Development, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; 4. Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; 5. Department of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, China
Respiratory syncytial virus in adults aged ≥ 50 years in France: a database and time-series modelling analysis (2014–2020)
AuthorsRachel M. Reeves; Saskia Hagenaars; Rita Ammoun; Bénédicte Borsik; Xavier Colin; Maria João Fonseca; Triantafyllos Pliakas; Emanuele Amodio; Colin A. Russell; Richard Osei-Yeboah; Alen Marijam; Paul Loubet
Affiliations1. GSK, Philadelphia, USA; 2. IQVIA Solutions, Amsterdam, The Netherlands; 3. IQVIA, Courbevoie, France; 4. IQVIA, Bordeaux, France; 5. GSK, Rueil-Malmaison, France; 6. GSK, Lisbon, Portugal; 7. GSK, Wavre, Belgium; 8. Impact Epilysis, Thessaloniki, Greece; 9. Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy; 10. Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centre, Amsterdam, The Netherlands; 11. Centre for Global Health, Usher Institute, The University of Edinburgh, Edinburgh, UK; 12. Virulence Bactérienne et Infections Chroniques, INSERM U1047, Univ Montpellier, Service des Maladies Infectieuses et Tropicales, CHU Nîmes, Nîmes, France
Impact of an antimicrobial stewardship intervention on carbapenem use in children with cancer
AuthorsSarina K. Butzer; Katrin Mehler; André Oberthuer; Lena M. Biehl; Benjamin Kuehne; Pablo Landgraf; Thorsten Simon; Norma Jung
Affiliations1. Department of Pediatrics, Division of Pediatric Infectious Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; 2. Department of Pediatrics, Division of Pediatric Hematology and Oncology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; 3. Department of Internal Medicine I, Division of Infectious Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; 4. German Centre for Infection Research, Cologne, Germany; 5. Department of Pediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
